MiNK Therapeutics, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6036931029
USD
12.35
1.63 (15.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
MiNK Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-10.00
-22.00
-27.00
-30.00
-16.00
-23.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
2.00
8.00
3.00
1.00
7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-9.00
-15.00
-18.00
-12.00
-8.00
-14.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
10.00
0.00
0.00
49.00
11.00
11.00
Net Cash Inflow / Outflow
1.00
-16.00
-19.00
36.00
2.00
-4.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of MiNK Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-10.784802
-29.959997
19.00
64.00%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.459728
1.087979
-1.00
-57.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-9.555476
-26.682581
17.00
64.19%
Cash Flow from Investing Activities
0
-21.089282
21.00
100.00%
Cash Flow from Financing Activities
10.819986
0.168337
10.00
6327.57%
Net Cash Inflow / Outflow
1.209811
-47.603526
48.00
102.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.054699
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 39.38% vs 16.45% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-9.56
-15.76
39.38%